SYBT:F:F-SSgA SPDR ETFs Europe I Public Limited Company - SPDR Barclays U.S. Treasury Bond UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 91.618

Change

0.00 (0.00)%

Market Cap

USD 0.49B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 111.88B
UIM5:F UBS (Lux) Fund Solutions - MSC..

N/A

USD 106.38B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 105.77B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 62.83B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 51.55B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 43.00B
0ZC:F Zscaler Inc

-7.28 (-3.85%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing SYBT:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.33% 26% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.33% 26% F 40% F
Trailing 12 Months  
Capital Gain 4.21% 34% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.21% 31% F 42% F
Trailing 5 Years  
Capital Gain -11.01% 14% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.01% 14% F 21% F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.49B 61% D- 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike